Greg Gianforte bought Novozymes AS (PINK: NVZMY)
Greg Gianforte (R-MT), a U.S. Representative, has disclosed 8 trades in Novozymes AS (NVZMY) since 2018, 5 purchases and 3 sales, worth an estimated $848K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a purchase: Greg Gianforte bought $100,001 - $250,000 of Novozymes AS (PINK: NVZMY) on December 21, 2018. Since that trade, NVZMY is up +63.46% against the S&P 500 up +237.91%, an outperformance of -174.45%.
Across these filings, Greg Gianforte has been a net buyer of NVZMY (a buy-to-sell ratio of 1.67). The most recent disclosed NVZMY transaction shown was dated August 4, 2020. Each row in the table below links to that trade and its post-trade performance versus the market.
Data updated
Greg Gianforte's NVZMY trades vs the price
NVZMY is up +63.46% since Greg Gianforte bought on December 21, 2018, versus +237.91% for the S&P 500.
Performance since this trade
All Greg Gianforte NVZMY trades
Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.
Greg Gianforte & NVZMY trading FAQ
Is it legal for Greg Gianforte to trade Novozymes AS (NVZMY) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Novozymes AS (NVZMY), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Greg Gianforte buy NVZMY?
Greg Gianforte disclosed a purchase of $100,001 - $250,000 of Novozymes AS (NVZMY) on December 21, 2018, according to public STOCK Act filings.
How has NVZMY performed since Greg Gianforte's trade?
Since Greg Gianforte bought NVZMY on December 21, 2018, the stock is up +63.46%, versus +237.91% for the S&P 500 over the same period, an outperformance of -174.45%.
How many times has Greg Gianforte traded NVZMY?
Greg Gianforte has disclosed 8 NVZMY trades since 2018 (5 purchases and 3 sales). Every disclosed trade is listed on this page.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional NVZMY trades?
Quantellect tracks every disclosed congressional trade in Novozymes AS (NVZMY) on the Novozymes AS congressional trading page, which aggregates filings across all members of Congress.
Greg Gianforte's NVZMY tradesAll congressional filings for Novozymes ASGreg Gianforte's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.